In Pursuance of Differentiation Inducers to Combat Cancer via Targeting of Abnormal Methylation Enzymes
Ming C. Liau, Jai-Hyun Kim & John P. Fruehauf · Journal of Cancer and Tumor International · 2020
Cell differentiation agent-2 (CDA-2) was a promising hypomethylating agent approved by the Chinese FDA for the therapy of MDS in China. The active components of CDA-2 are differentiation inducers (DIs) and differentiation helper inducers (DHIs). DIs are chemicals capable of elimi...
Open access
Research Article
10.9734/jcti/2020/v10i230125